Most Recent
S&P may ask judge to disqualify himself from class action over ratings defects
A judge who oversaw a 39-day trial in 2018 in multiple class actions against S&P Global may be asked by the ratings agency to step down from hearing another class action alleging systemic defects in its ratings systems.
Linchpin Capital investors want to add insurers to class action
A class action by investors of collapsed Linchpin Capital against the company's former directors wants to join their insurers as defendants to the proceedings.
Judge won’t entertain defective defence argument in negligence case against K&L Gates
K&L Gates has fended off a mid-case bid for costs by former clients who are seeking $3 million in a negligence lawsuit and told a court on Wednesday they wasted money responding to a "defective defence" by the law firm.
Barrister struck off roll for practising in NSW without a certificate for 6 years
A former barrister has been struck off the roll of practitioners in NSW after it was found that he practised in the state for six years without a local practising certificate and lied to the Queensland Bar Association about the location of his practice.
L’Oreal opposition to Lore Perfumery trade mark doesn’t pass the smell test
Cosmetics giant L’Oreal has lost its opposition to Melbourne-based Lore Perfumery's 'Lore' trade mark, with an IP Australia delegate finding that L’Oreal’s strong reputation made it unlikely that consumers would be deceived or confused.
Private equity firm entitled to interest in $6M spat with ex-Atrum Coal boss, court says
Three units of Hong Kong private equity group Argonaut have successfully defended an appeal by former Atrum Coal director Russell Moran who was ordered to repay $6 million plus interest after defaulting on a loan he had "no capacity" to repay.
Judge pushes for trial early next year in Opal Tower class action
A judge has suggested hearing the long-running class action over the Opal Tower disaster as early as the first quarter of next year, as the court juggles three concurrent lawsuits and a slew of cross-claims over the doomed building.
Juno and Bristol-Myers Squibb suffer losses in Revlimid patent war
A patent battle between Juno Pharmaceuticals and Bristol-Myers Squibb over the blockbuster drug Revlimid has seen both sides suffer early losses, with a judge dismissing strike out and summary dismissal applications by the drug makers.
Clough appeals tax ruling on $15M in cancellation of entitlements
Construction company Clough Limited has appealed a ruling that found it cannot claim over $15 million paid to employees for cancellation of their shares and options as a tax deduction.
UNSW accused of firing professor who complained of sex discrimination
The University of New South Wales has been taken to court by a former tenured professor who alleges she was terminated after making complaints about discrimination against female academics, bullying and misuse of her intellectual property.